A phase II trial testing the thermal dose parameter CEM43 degrees T90 as a predictor of response in soft tissue sarcomas treated with pre-operative thermoradiotherapy.

Maguire, P D; Samulski, T V; Prosnitz, L R; Jones, E L; Rosner, G L; Powers, B; Layfield, L W; Brizel, D M; Scully, S P; Harrelson, J M; Dewhirst, M W

Maguire, P D; Samulski, T V; Prosnitz, L R; Jones, E L; Rosner, G L; Powers, B; Layfield, L W; Brizel, D M; Scully, S P; Harrelson, J M; Dewhirst, M W.

Affiliation

Maguire PD; Department of Radiation Oncology, Duke University Medical Center, Durham, NC 27710, USA.

Int J Hyperthermia ; 17(4): 283-90, 2001.

Article in En | MEDLINE | ID: mdl-11471980

Subject(s)

Hyperthermia, Induced; Sarcoma/therapy; Adult; Aged; Aged, 80 and over; Combined Modality Therapy; Female; Humans; Male; Middle Aged; Preoperative Care; Prospective Studies; Sarcoma/radiotherapy; Sarcoma/surgery; Treatment Outcome

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Sarcoma / Hyperthermia, Induced Type of study: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Int J Hyperthermia Year: 2001 Document type: Article

Search on Google

XML

PubMed Links